XPERT? breast cancer STRAT4 as an alternative method of identifying breast cancer phenotype in Cape Verde (preliminary results)

被引:1
作者
Borges, Pamela C. C. [1 ]
Spencer, Hirondina B. [2 ]
Barbosa, Carla [2 ,5 ]
Costa, Victor [2 ]
Furtado, Antonia [3 ]
Leal, Maria Conceicao [4 ]
Lopes, Carlos
Ferreira, Dylan [6 ]
Carvalho, Andre Lopes [7 ]
Dos-Santos-Silva, Isabel [8 ]
Santos, Lucio Lara [9 ]
机构
[1] Hosp Univ Agostinho Neto, Lab Biol Mol, Plateau 112, Praia, Cape Verde
[2] Hosp Univ Agostinho Neto, Plateau 112, Praia, Cape Verde
[3] IMP Diagnost, Mol & Anat Pathol Lab, P-4150146 Porto, Portugal
[4] Inst Portugues Oncol Francisco Gentil, Anat Patol, P-4200072 Porto, Portugal
[5] Unilabs Lab Anat Patol, P-4250170 Porto, Portugal
[6] Portuguese Oncol Inst Porto IPO Porto, CI IPOP RISECI IPOP Hlth Res Network, Porto Comprehens Canc Ctr Porto CCC, Res Ctr IPO Porto,Expt Pathol & Therapeut Grp, P-4200072 Porto, Portugal
[7] Int Agcy Res Canc, F-69007 Lyon, France
[8] London Sch Hyg & Trop Med, London WC1E 7HT, England
[9] Portuguese Inst Oncol, Surg Oncol Dept, P-4200072 Porto, Portugal
来源
ECANCERMEDICALSCIENCE | 2023年 / 17卷
关键词
MESSENGER-RNA; IMMUNOHISTOCHEMISTRY; SYSTEM;
D O I
10.3332/ecancer.2023.1530
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Breast cancer (BC) is a public health problem in developing countries, including Cape Verde. Immunohistochemistry (IHC) is the gold standard technique used for BC phenotypic characterisation to support efficient therapeutic decisions. However, IHC is a demanding technique that requires knowledge, trained technicians, expensive antibodies and reagents, controls, and results validation. The low number of cases in Cape Verde increases the risk of expiring the validity of the antibodies, and manual procedures often jeopardise the quality of the results. Thus, IHC is limited in Cape Verde, and an alternative technically easy solution is needed. A point-of-care messenger RNA (mRNA) STRAT4 BC assay to assess estrogen (ER), progesterone (PR), hormone growth factor 2 receptor (HER2), and Ki67, using the GeneXpert platform, has been recently validated on tissues from internationally accredited laboratories, showing excellent concordance with IHC results.To assess whether this technology can be implemented in Cape Verde to guide BC treat-ment we decided to study the level of agreement between the findings yielded by BC STRAT4 and the results are the same cases obtained by IHC.Methods: Formalin-fixed and paraffin-embedded (FFPE) tissue samples from 29 Cabo Verdean BC patients diagnosed in Agostinho Neto University Hospital were analysed by applying IHC and BC STRAT4 assay. The time between sample collection and pre-analytic procedures is unknown. All the samples were pre-processed in Cabo Verde (fixed in for-malin and embedded in paraffin). IHC studies were performed in referenced laboratories in Portugal. STRAT4 and IHC result concordance was assessed by calculating the per-centage of results agreement and Cohen's Kappa (K) statistics.Results: STRAT4 assay failed in 2 out of the 29 analysed samples. Of the 27 successfully analysed samples, STRAT4/IHC results for ER, PR, HER2, and Ki67 were concordant in 25, 24, 25, and 18 cases, respectively. Ki67 was indeterminate in three cases, and PR was indeterminate once.
引用
收藏
页数:14
相关论文
共 40 条
  • [1] Adebamowo CA, 2022, J CLIN ONCOL, V40
  • [2] Estimating the incidence of breast cancer in Africa: a systematic review and meta-analysis
    Adeloye, Davies
    Adeloye, Davies
    Sowunmi, Olaperi Y.
    Jacobs, Wura
    David, Rotimi A.
    Adeosun, Adeyemi A.
    Amuta, Ann O.
    Misra, Sanjay
    Gadanya, Muktar
    Auta, Asa
    Harhay, Michael O.
    Chan, Kit Yee
    [J]. JOURNAL OF GLOBAL HEALTH, 2018, 8 (01)
  • [3] Emerging breast cancer epidemic: evidence from Africa
    Akarolo-Anthony, Sally N.
    Ogundiran, Temidayo O.
    Adebamowo, Clement A.
    [J]. BREAST CANCER RESEARCH, 2010, 12
  • [4] Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update
    Allison, Kimberly H.
    Hammond, M. Elizabeth H.
    Dowsett, Mitchell
    McKernin, Shannon E.
    Carey, Lisa A.
    Fitzgibbons, Patrick L.
    Hayes, Daniel F.
    Lakhani, Sunil R.
    Chavez-MacGregor, Mariana
    Perlmutter, Jane
    Perou, Charles M.
    Regan, Meredith M.
    Rimm, David L.
    Symmans, W. Fraser
    Torlakovic, Emina E.
    Varella, Leticia
    Viale, Giuseppe
    Weisberg, Tracey F.
    McShane, Lisa M.
    Wolff, Antonio C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (12) : 1346 - +
  • [5] The Global Breast Cancer Initiative: a strategic collaboration to strengthen health care for non-communicable diseases
    Anderson, Benjamin O.
    Ilbawi, Andre M.
    Fidarova, Elena
    Weiderpass, Elisabete
    Stevens, Lisa
    Abdel-Wahab, May
    Mikkelsen, Bente
    [J]. LANCET ONCOLOGY, 2021, 22 (05) : 578 - 581
  • [6] Immunohistochemistry for diagnosis and prognosis of breast cancer: a review
    Bonacho, T.
    Rodrigues, F.
    Liberal, J.
    [J]. BIOTECHNIC & HISTOCHEMISTRY, 2020, 95 (02) : 71 - 91
  • [7] Cape Verde Institute for Health Metrics and Evaluation, US
  • [8] Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Cardoso, F.
    Kyriakides, S.
    Ohno, S.
    Penault-Llorca, F.
    Poortmans, P.
    Rubio, I. T.
    Zackrisson, S.
    Senkus, E.
    [J]. ANNALS OF ONCOLOGY, 2019, 30 (08) : 1194 - 1220
  • [9] Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
    Cheang, Maggie C. U.
    Chia, Stephen K.
    Voduc, David
    Gao, Dongxia
    Leung, Samuel
    Snider, Jacqueline
    Watson, Mark
    Davies, Sherri
    Bernard, Philip S.
    Parker, Joel S.
    Perou, Charles M.
    Ellis, Matthew J.
    Nielsen, Torsten O.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (10): : 736 - 750
  • [10] Epidemiological transition and double burden of diseases in low-income countries: the case of Mozambique
    Ciccacci, Fausto
    Orlando, Stefano
    Majid, Noorjehan
    Marazzi, Cristina
    [J]. PAN AFRICAN MEDICAL JOURNAL, 2020, 37 : 1 - 8